Lumigenex is a fast growing biotechnology company dedicated to the development of proprietary technologies that meet the ever increasing demands on clinical diagnostics. Lumigenex is focused on developing cost-effective rapid diagnostic products based on our patented Time Resolved Fluorescence Immunoassay (TRFIA) platform with primary areas of interests in cardiology, women's health, infectious disease, oncology and drugs of abuse. Closely collaborating with our global strategic partners, Lumigenex is committed to becoming a worldwide leader in the fields of quantitative POCT.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.